Viridian Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Viridian Therapeutics has a total shareholder equity of $442.0M and total debt of $20.2M, which brings its debt-to-equity ratio to 4.6%. Its total assets and total liabilities are $490.4M and $48.4M respectively.
Key information
4.6%
Debt to equity ratio
US$20.21m
Debt
Interest coverage ratio | n/a |
Cash | US$477.37m |
Equity | US$442.02m |
Total liabilities | US$48.40m |
Total assets | US$490.42m |
Recent financial health updates
Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Recent updates
Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?
May 15Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market
Sep 09Viridian Therapeutics board compensation committee approves inducement grants
Sep 02An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued
Aug 22Viridian Therapeutics Q2 2022 Earnings Preview
Aug 12Viridian Therapeutics gets a new COO
Jun 23Viridian Therapeutics (VRDN) Investor Presentation - Slideshow
Jun 08Viridian Therapeutics reports Q1 results
May 06Financial Position Analysis
Short Term Liabilities: VRDN's short term assets ($486.5M) exceed its short term liabilities ($26.6M).
Long Term Liabilities: VRDN's short term assets ($486.5M) exceed its long term liabilities ($21.8M).
Debt to Equity History and Analysis
Debt Level: VRDN has more cash than its total debt.
Reducing Debt: VRDN's debt to equity ratio has reduced from 20.1% to 4.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VRDN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VRDN has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 36.3% each year.